Cat. No.: X23-10-ZQ174
RIP kinase inhibitor GSK2982772, Purity ≥98%
Synonym: 1622848-92-3; GSK2982772; GSK-2982772; (S)-5-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1H-1,2,4-triazole-3-carboxamide; (S)-3-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1H-1,2,4-triazole-5-carboxamide; RIP kinase inhibitor
- MDL: MFCD30828708
- CAS Number: 1622848-92-3
- Compound CID: 77108121
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Properties
Description
GSK2982772, soluble in DMSO and ethanol and insoluble in water, is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.
Molecular Formula
C20H19N5O3
Solubility
DMSO: 66 mg/mL (174.87 mM); Water: Insoluble; Ethanol: 26 mg/mL (68.89 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
GSK2982772 can be studied for its potential to inhibit RIPK1 in inflammatory and autoimmune disease research.
Related Products
